United States Biotechnology & Medical Research

Senseonics Holdings Inc (SENS)

Track

Track

Senseonics Holdings Inc has seen no insider trading activity within the past ninety days. The most recent recorded transactions occurred on May 12, 2026, involving a purchase by Douglas A. Roeder. Historical data indicates a pattern of buying interest from key executives and stakeholders prior to this period.
Ticker: SENS Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Senseonics Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
4.0
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Purchase
Price
363.84
Quantity 63,580 +47.3%
Value US$4,782,460
3.5
Goodnow Timothy T President and CEO Executive Director
Transaction date
Purchase
Price
469.19
Quantity 87,579 -15.8%
Value US$2,923,968
4.0
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Purchase
Price
162.53
Quantity 22,562 +29.3%
Value US$3,535,861
2.4
Steven Edelman Non-Executive Director
Transaction date
Purchase
Price
6.55
Quantity 10,000 +15.5%
Value US$65,500
3.8
Sullivan Frederick T. Chief Financial Officer Officer
Transaction date
Purchase
Price
5.88
Quantity 5,415 +3.6%
Value US$31,840
4.0
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Purchase
Price
5.83
Quantity 15,000 +17.7%
Value US$87,450
4.0
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Purchase
Price
0.50
Quantity 25,000 +1.8%
Value US$12,500
4.0
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Purchase
Price
0.41
Quantity 300,000 +27.6%
Value US$123,000
3.8
Sullivan Frederick T. Chief Financial Officer Officer
Transaction date
Purchase
Price
0.38
Quantity 124,933 +5.3%
Value US$47,475
3.5
Goodnow Timothy T President and CEO Executive Director
Transaction date
Purchase
Price
0.31
Quantity 315,000 +2.9%
Value US$97,650
Larkin Sharon Non-Executive Director
Transaction date
Planned sale
Price
0.61
Quantity 30,889 -9.6%
Value US$18,842
SHARON D LARKIN Officer Officer
Transaction date
Proposed sale
Price
0.62
Quantity 30,889
Value US$19,151
4.0
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Purchase
Price
0.54
Quantity 300,000 +59.1%
Value US$162,000
3.3
JAIN Mukul Chief Operating Officer Officer
Transaction date
Planned sale
Price
1.97
Quantity 50,000 -2.0%
Value US$98,500
2.4
Fiorentino Edward Non-Executive Director
Transaction date
Sale
Price
1.65
Quantity 63,553 -12.9%
Value US$104,862
3.3
Kaufman Francine Chief Medical Officer Executive Director
Transaction date
Sale
Price
2.46
Quantity 163,870 -11.8%
Value US$403,120
3.5
Goodnow Timothy T President and CEO Executive Director
Transaction date
Sale
Price
2.46
Quantity 464,390 -8.9%
Value US$1,142,399
3.3
JAIN Mukul Chief Operating Officer Officer
Transaction date
Sale
Price
2.46
Quantity 150,197 -7.5%
Value US$369,485
3.3
Panlilio Mirasol VP Global Sales and Marketing Officer
Transaction date
Sale
Price
2.46
Quantity 105,760 -8.9%
Value US$260,170
3.3
Tressler Nick B. Chief Financial Officer Officer
Transaction date
Sale
Price
2.46
Quantity 72,873 -19.2%
Value US$179,268
3.3
Horton Kenneth L GC & Corp. Development Advisor Officer
Transaction date
Sale
Price
2.46
Quantity 143,126 -10.5%
Value US$352,090
Raab Anthony R. Non-Executive Director
Transaction date
Planned sale
Price
2.53
Quantity 136,538 -38.6%
Value US$345,441
3.3
JAIN Mukul Chief Operating Officer Officer
Transaction date
Planned sale
Price
3.70
Quantity 100,000 -5.4%
Value US$370,000
3.3
Kaufman Francine Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
3.70
Quantity 20,998 -1.9%
Value US$77,693
3.3
JAIN Mukul Chief Operating Officer Officer
Transaction date
Planned sale
Price
4.36
Quantity 50,000 -2.5%
Value US$218,000
3.3
Kaufman Francine Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
4.00
Quantity 62,628 -5.6%
Value US$250,512
3.5
Goodnow Timothy T President and CEO Executive Director
Transaction date
Planned sale
Price
3.60
Quantity 380,710 -7.3%
Value US$1,370,556
3.3
JAIN Mukul Chief Operating Officer Officer
Transaction date
Planned sale
Price
3.51
Quantity 18,866 -0.9%
Value US$66,220
3.3
JAIN Mukul Chief Operating Officer Officer
Transaction date
Planned sale
Price
3.50
Quantity 6,134 -0.3%
Value US$21,469
3.3
Kaufman Francine Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
3.00
Quantity 62,627 -5.4%
Value US$187,881
3.3
JAIN Mukul Chief Operating Officer Officer
Transaction date
Planned sale
Price
2.70
Quantity 25,000 -1.3%
Value US$67,500
4.0
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Planned sale
Price
1.91
Quantity 147,735 -54.1%
Value US$282,174
Prince Douglas S Non-Executive Director
Transaction date
Planned sale
Price
1.90
Quantity 136,539 -37.1%
Value US$259,424
2.4
Fiorentino Edward Non-Executive Director
Transaction date
Planned sale
Price
1.91
Quantity 109,231 -24.7%
Value US$208,631
4.0
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Sale
Price
2.08
Quantity 652 -100.0%
Value US$1,358
4.0
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Planned sale
Price
2.12
Quantity 47,580 -98.6%
Value US$100,884
4.0
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Planned sale
Price
2.12
Quantity 4,906,326 -100.0%
Value US$10,402,883
4.0
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Planned sale
Price
2.39
Quantity 46,989 -49.3%
Value US$112,191
4.0
ROEDER DOUGLAS A Non-Executive Director
Transaction date
Planned sale
Price
2.39
Quantity 4,845,399 -50.0%
Value US$11,568,875
3.5
Goodnow Timothy T President and CEO Executive Director
Transaction date
Planned sale
Price
0.71
Quantity 80,000 -15.5%
Value US$56,800
3.5
Goodnow Timothy T President and CEO Executive Director
Transaction date
Planned sale
Price
1.28
Quantity 80,000 -15.8%
Value US$102,400
3.5
Goodnow Timothy T President and CEO Executive Director
Transaction date
Purchase
Price
1.10
Quantity 88,500 +26.3%
Value US$97,350
JAIN Mukul Chief Operating Officer Officer
Transaction date
Planned sale
Price
4.50
Quantity 40,000 -100.0%
Value US$180,196
ROEDER DOUGLAS A
Transaction date
Planned sale
Price
4.05
Quantity 5,910 -5.8%
Value US$23,930
ROEDER DOUGLAS A
Transaction date
Planned sale
Price
4.05
Quantity 605,355 -5.8%
Value US$2,451,082
ROEDER DOUGLAS A
Transaction date
Planned sale
Price
3.96
Quantity 1,501 -1.5%
Value US$5,951
ROEDER DOUGLAS A
Transaction date
Planned sale
Price
3.96
Quantity 153,723 -1.5%
Value US$609,435
ROEDER DOUGLAS A
Transaction date
Planned sale
Price
3.96
Quantity 2,068 -2.0%
Value US$8,199
ROEDER DOUGLAS A
Transaction date
Planned sale
Price
3.96
Quantity 211,832 -2.0%
Value US$839,829
ROEDER DOUGLAS A
Transaction date
Planned sale
Price
3.91
Quantity 2,536 -2.4%
Value US$9,903
ROEDER DOUGLAS A
Transaction date
Planned sale
Price
3.91
Quantity 259,690 -2.4%
Value US$1,014,115
ROEDER DOUGLAS A
Transaction date
Planned sale
Price
3.84
Quantity 2,489 -2.3%
Value US$9,547
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-13 2026-05-12 B Purchase
4.0
ROEDER DOUGLAS A
Non-Executive Director
63,580 +47.3%
363.84
US$4,782,460 		63,580 +47.3% 363.84 US$4,782,460
2026-03-16 2026-03-13 B Purchase
3.5
Goodnow Timothy T

President and CEO

Executive Director
87,579 -15.8%
469.19
US$2,923,968 		87,579 -15.8% 469.19 US$2,923,968
2026-03-16 2026-03-13 B Purchase
4.0
ROEDER DOUGLAS A
Non-Executive Director
22,562 +29.3%
162.53
US$3,535,861 		22,562 +29.3% 162.53 US$3,535,861
2025-11-13 2025-11-10 B Purchase
2.4
Steven Edelman
Non-Executive Director
10,000 +15.5%
6.55
US$65,500 		10,000 +15.5% 6.55 US$65,500
2025-11-10 2025-11-07 B Purchase
3.8
Sullivan Frederick T.

Chief Financial Officer

Officer
5,415 +3.6%
5.88
US$31,840 		5,415 +3.6% 5.88 US$31,840
2025-11-10 2025-11-07 B Purchase
4.0
ROEDER DOUGLAS A
Non-Executive Director
15,000 +17.7%
5.83
US$87,450 		15,000 +17.7% 5.83 US$87,450
2024-12-16 2024-12-13 B Purchase
4.0
ROEDER DOUGLAS A
Non-Executive Director
25,000 +1.8%
0.50
US$12,500 		25,000 +1.8% 0.50 US$12,500
2024-12-16 2024-12-12 B Purchase
4.0
ROEDER DOUGLAS A
Non-Executive Director
300,000 +27.6%
0.41
US$123,000 		300,000 +27.6% 0.41 US$123,000
2024-12-12 2024-12-12 B Purchase
3.8
Sullivan Frederick T.

Chief Financial Officer

Officer
124,933 +5.3%
0.38
US$47,475 		124,933 +5.3% 0.38 US$47,475
2024-12-10 2024-12-10 B Purchase
3.5
Goodnow Timothy T

President and CEO

Executive Director
315,000 +2.9%
0.31
US$97,650 		315,000 +2.9% 0.31 US$97,650
2023-09-08 2023-09-07 PlS Planned sale
Larkin Sharon
Non-Executive Director
30,889 -9.6%
0.61
US$18,842 		30,889 -9.6% 0.61 US$18,842
2023-09-07 2023-09-07 PrS Proposed sale
SHARON D LARKIN

Officer

Officer
30,889
0.62
US$19,151 		30,889 0.62 US$19,151
2023-08-31 2023-08-30 B Purchase
4.0
ROEDER DOUGLAS A
Non-Executive Director
300,000 +59.1%
0.54
US$162,000 		300,000 +59.1% 0.54 US$162,000
2022-08-05 2022-08-04 PlS Planned sale
3.3
JAIN Mukul

Chief Operating Officer

Officer
50,000 -2.0%
1.97
US$98,500 		50,000 -2.0% 1.97 US$98,500
2022-03-15 2022-03-11 S Sale
2.4
Fiorentino Edward
Non-Executive Director
63,553 -12.9%
1.65
US$104,862 		63,553 -12.9% 1.65 US$104,862
2022-02-14 2022-02-11 S Sale
3.3
Kaufman Francine

Chief Medical Officer

Executive Director
163,870 -11.8%
2.46
US$403,120 		163,870 -11.8% 2.46 US$403,120
2022-02-14 2022-02-11 S Sale
3.5
Goodnow Timothy T

President and CEO

Executive Director
464,390 -8.9%
2.46
US$1,142,399 		464,390 -8.9% 2.46 US$1,142,399
2022-02-14 2022-02-11 S Sale
3.3
JAIN Mukul

Chief Operating Officer

Officer
150,197 -7.5%
2.46
US$369,485 		150,197 -7.5% 2.46 US$369,485
2022-02-14 2022-02-11 S Sale
3.3
Panlilio Mirasol

VP Global Sales and Marketing

Officer
105,760 -8.9%
2.46
US$260,170 		105,760 -8.9% 2.46 US$260,170
2022-02-14 2022-02-11 S Sale
3.3
Tressler Nick B.

Chief Financial Officer

Officer
72,873 -19.2%
2.46
US$179,268 		72,873 -19.2% 2.46 US$179,268
2022-02-14 2022-02-11 S Sale
3.3
Horton Kenneth L

GC & Corp. Development Advisor

Officer
143,126 -10.5%
2.46
US$352,090 		143,126 -10.5% 2.46 US$352,090
2021-12-08 2021-12-06 PlS Planned sale
Raab Anthony R.
Non-Executive Director
136,538 -38.6%
2.53
US$345,441 		136,538 -38.6% 2.53 US$345,441
2021-11-18 2021-11-16 PlS Planned sale
3.3
JAIN Mukul

Chief Operating Officer

Officer
100,000 -5.4%
3.70
US$370,000 		100,000 -5.4% 3.70 US$370,000
2021-11-18 2021-11-16 PlS Planned sale
3.3
Kaufman Francine

Chief Medical Officer

Executive Director
20,998 -1.9%
3.70
US$77,693 		20,998 -1.9% 3.70 US$77,693
2021-06-16 2021-06-14 PlS Planned sale
3.3
JAIN Mukul

Chief Operating Officer

Officer
50,000 -2.5%
4.36
US$218,000 		50,000 -2.5% 4.36 US$218,000
2021-06-15 2021-06-11 PlS Planned sale
3.3
Kaufman Francine

Chief Medical Officer

Executive Director
62,628 -5.6%
4.00
US$250,512 		62,628 -5.6% 4.00 US$250,512
2021-06-14 2021-06-10 PlS Planned sale
3.5
Goodnow Timothy T

President and CEO

Executive Director
380,710 -7.3%
3.60
US$1,370,556 		380,710 -7.3% 3.60 US$1,370,556
2021-06-11 2021-06-10 PlS Planned sale
3.3
JAIN Mukul

Chief Operating Officer

Officer
18,866 -0.9%
3.51
US$66,220 		18,866 -0.9% 3.51 US$66,220
2021-06-11 2021-06-09 PlS Planned sale
3.3
JAIN Mukul

Chief Operating Officer

Officer
6,134 -0.3%
3.50
US$21,469 		6,134 -0.3% 3.50 US$21,469
2021-06-08 2021-06-04 PlS Planned sale
3.3
Kaufman Francine

Chief Medical Officer

Executive Director
62,627 -5.4%
3.00
US$187,881 		62,627 -5.4% 3.00 US$187,881
2021-06-08 2021-06-04 PlS Planned sale
3.3
JAIN Mukul

Chief Operating Officer

Officer
25,000 -1.3%
2.70
US$67,500 		25,000 -1.3% 2.70 US$67,500
2021-05-28 2021-05-25 PlS Planned sale
4.0
ROEDER DOUGLAS A
Non-Executive Director
147,735 -54.1%
1.91
US$282,174 		147,735 -54.1% 1.91 US$282,174
2021-05-27 2021-05-25 PlS Planned sale
Prince Douglas S
Non-Executive Director
136,539 -37.1%
1.90
US$259,424 		136,539 -37.1% 1.90 US$259,424
2021-05-27 2021-05-25 PlS Planned sale
2.4
Fiorentino Edward
Non-Executive Director
109,231 -24.7%
1.91
US$208,631 		109,231 -24.7% 1.91 US$208,631
2021-05-21 2021-05-19 S Sale
4.0
ROEDER DOUGLAS A
Non-Executive Director
652 -100.0%
2.08
US$1,358 		652 -100.0% 2.08 US$1,358
2021-04-13 2021-04-12 PlS Planned sale
4.0
ROEDER DOUGLAS A
Non-Executive Director
47,580 -98.6%
2.12
US$100,884 		47,580 -98.6% 2.12 US$100,884
2021-04-13 2021-04-12 PlS Planned sale
4.0
ROEDER DOUGLAS A
Non-Executive Director
4,906,326 -100.0%
2.12
US$10,402,883 		4,906,326 -100.0% 2.12 US$10,402,883
2021-04-13 2021-04-09 PlS Planned sale
4.0
ROEDER DOUGLAS A
Non-Executive Director
46,989 -49.3%
2.39
US$112,191 		46,989 -49.3% 2.39 US$112,191
2021-04-13 2021-04-09 PlS Planned sale
4.0
ROEDER DOUGLAS A
Non-Executive Director
4,845,399 -50.0%
2.39
US$11,568,875 		4,845,399 -50.0% 2.39 US$11,568,875
2020-04-29 2020-04-29 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
144,538 -0.7%
0.60
US$87,156 		144,538 -0.7% 0.60 US$87,156
2020-04-29 2020-04-28 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
31,228 -0.2%
0.60
US$18,834 		31,228 -0.2% 0.60 US$18,834
2020-04-29 2020-04-27 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
95,469 -0.5%
0.62
US$59,611 		95,469 -0.5% 0.62 US$59,611
2020-04-23 2020-04-22 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
119,712 -0.6%
0.63
US$75,861 		119,712 -0.6% 0.63 US$75,861
2020-04-23 2020-04-21 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
45,349 -0.2%
0.66
US$29,998 		45,349 -0.2% 0.66 US$29,998
2020-04-20 2020-04-20 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
94,663 -0.5%
0.69
US$65,270 		94,663 -0.5% 0.69 US$65,270
2020-04-20 2020-04-17 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
59,135 -0.3%
0.68
US$40,241 		59,135 -0.3% 0.68 US$40,241
2020-04-20 2020-04-16 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
49,786 -0.2%
0.67
US$33,416 		49,786 -0.2% 0.67 US$33,416
2020-04-15 2020-04-15 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
59,569 -0.3%
0.68
US$40,376 		59,569 -0.3% 0.68 US$40,376
2020-04-15 2020-04-14 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
48,564 -0.2%
0.68
US$33,227 		48,564 -0.2% 0.68 US$33,227
2020-04-15 2020-04-13 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
70,184 -0.3%
0.66
US$46,364 		70,184 -0.3% 0.66 US$46,364
2020-04-09 2020-04-09 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
128,301 -0.6%
0.67
US$85,525 		128,301 -0.6% 0.67 US$85,525
2020-04-09 2020-04-08 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
98,802 -0.5%
0.63
US$62,403 		98,802 -0.5% 0.63 US$62,403
2020-04-09 2020-04-07 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
101,116 -0.5%
0.62
US$62,722 		101,116 -0.5% 0.62 US$62,722
2020-04-06 2020-04-06 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
119,929 -0.6%
0.59
US$70,710 		119,929 -0.6% 0.59 US$70,710
2020-04-06 2020-04-03 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
59,699 -0.3%
0.52
US$31,336 		59,699 -0.3% 0.52 US$31,336
2020-04-06 2020-04-02 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
111,699 -0.5%
0.56
US$62,261 		111,699 -0.5% 0.56 US$62,261
2020-04-01 2020-04-01 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
42,935 -0.2%
0.58
US$24,842 		42,935 -0.2% 0.58 US$24,842
2020-04-01 2020-03-31 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
79,919 -0.4%
0.63
US$50,069 		79,919 -0.4% 0.63 US$50,069
2020-04-01 2020-03-30 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
171,667 -0.8%
0.63
US$108,682 		171,667 -0.8% 0.63 US$108,682
2020-03-27 2020-03-27 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
175,356 -0.8%
0.67
US$116,857 		175,356 -0.8% 0.67 US$116,857
2020-03-27 2020-03-26 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
261,503 -1.2%
0.74
US$192,440 		261,503 -1.2% 0.74 US$192,440
2020-03-27 2020-03-25 S Sale
3.8
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
265,646 -1.2%
0.80
US$212,809 		265,646 -1.2% 0.80 US$212,809
2020-03-18 2020-03-16 PlS Planned sale
3.5
Goodnow Timothy T

President and CEO

Executive Director
80,000 -15.5%
0.71
US$56,800 		80,000 -15.5% 0.71 US$56,800
2020-03-11 2020-03-09 PlS Planned sale
3.5
Goodnow Timothy T

President and CEO

Executive Director
80,000 -15.8%
1.28
US$102,400 		80,000 -15.8% 1.28 US$102,400
2019-09-11 2019-09-09 B Purchase
3.5
Goodnow Timothy T

President and CEO

Executive Director
88,500 +26.3%
1.10
US$97,350 		88,500 +26.3% 1.10 US$97,350
2018-06-21 2018-06-19 PlS Planned sale JAIN Mukul

Chief Operating Officer

Officer
40,000 -100.0%
4.50
US$180,196 		40,000 -100.0% 4.50 US$180,196
2018-06-15 2018-06-15 PlS Planned sale ROEDER DOUGLAS A
5,910 -5.8%
4.05
US$23,930 		5,910 -5.8% 4.05 US$23,930
2018-06-15 2018-06-15 PlS Planned sale ROEDER DOUGLAS A
605,355 -5.8%
4.05
US$2,451,082 		605,355 -5.8% 4.05 US$2,451,082
2018-06-15 2018-06-14 PlS Planned sale ROEDER DOUGLAS A
1,501 -1.5%
3.96
US$5,951 		1,501 -1.5% 3.96 US$5,951
2018-06-15 2018-06-14 PlS Planned sale ROEDER DOUGLAS A
153,723 -1.5%
3.96
US$609,435 		153,723 -1.5% 3.96 US$609,435
2018-06-15 2018-06-13 PlS Planned sale ROEDER DOUGLAS A
2,068 -2.0%
3.96
US$8,199 		2,068 -2.0% 3.96 US$8,199
2018-06-15 2018-06-13 PlS Planned sale ROEDER DOUGLAS A
211,832 -2.0%
3.96
US$839,829 		211,832 -2.0% 3.96 US$839,829
2018-06-13 2018-06-12 PlS Planned sale ROEDER DOUGLAS A
2,536 -2.4%
3.91
US$9,903 		2,536 -2.4% 3.91 US$9,903
2018-06-13 2018-06-12 PlS Planned sale ROEDER DOUGLAS A
259,690 -2.4%
3.91
US$1,014,115 		259,690 -2.4% 3.91 US$1,014,115
2018-06-13 2018-06-11 PlS Planned sale ROEDER DOUGLAS A
2,489 -2.3%
3.84
US$9,547 		2,489 -2.3% 3.84 US$9,547
Explore more

More insider trading research around Senseonics Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America